Adriana Kaczaraj Malone MD

Hematologic Oncology

System Vice Chair for Education, Department of Medicine; Director, Hematology/Oncology and BMT Fellowship Programs; Associate Professor of Medicine and Medical Education Icahn School of Medicine at Mount Sinai

Join to View Full Profile

10 E 102nd StNew York, NY 10029
Phone+1 212-241-6756

Summary

Dr. Adriana Malone is Associate Professor of Medicine (Hematology/Medical Oncology) and Medical Education at the Icahn School of Medicine at Mount Sinai with a clinical focus on stem cell transplantation and cellular therapy. Dr. Malone has a long-standing interest in medical education and leadership. She directs the Hematology/Oncology and Stem Cell Transplant fellowships, served as Senior Associate Dean for Graduate Medical Education from 2020-2024, and was appointed System Vice Chair for Education, Department of Medicine as of January 2025. Dr. Malone was selected as a 2023 recipient of ACGME's prestigious Parker J. Palmer Courage to Teach Award for her work as a program director. On a national level, Dr. Malone is an active member of the American Society for Clinical Oncology and the American Society for Transplant and Cellular Therapy and has participated in education and leadership training as well as has served in leadership roles on education focused committees.

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2004 - 2007
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2000 - 2003
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2000
Columbia College, Columbia UniversityB.A., Biology, 1995

Certifications & Licensure

NY State Medical License 2001 - 2026
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Parker J. Palmer Courage to Teach Award ACGME, 2023
Icahn School of Medicine at Mount Sinai - Department of Medicine Teaching Award 2011-2012 for Resident/Fellow Teaching Icahn School of Medicine at Mount Sinai, 2012
Department of Medicine Teaching Award Icahn School of Medicine at Mount Sinai, 2012
Richard E. Rosenfield Faculty Achievement Award Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, 2011
John Watson Award in Medicine for Enthusiasm & Commitment to Scholarship in Medicine 2000
Janet M. Glasgow Memorial Achievement Citation American Medical Women's Association, 2000
Dean's Letter of Commendation University of Buffalo School of Medicine and Biomedical Sciences, 1997
Dean's List Columbia College, Columbia University, 1991
National Science Scholar Columbia College, Columbia University, 1991
Join now to see all

Clinical Trials

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901) Start of enrollment: 2011 Jun 01
Terminated
Phase 3
Double Cord Versus Haploidentical (BMT CTN 1101) Start of enrollment: 2012 Jun 01
Completed
Phase 3

Publications & Presentations

PubMed

2 citations
Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy.
Santiago Mercadal, Kwang Woo Ahn, Mariam Allbee-Johnson, Siddhartha Ganguly, Praveen Ramakrishnan Geethakumari
Haematologica. 2025-01-01
4 citations
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.
Tania Jain, Noel Estrada-Merly, M Queralt Salas, Soyoung Kim, Jakob DeVos
Blood Advances. 2024-08-27
5 citations
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open f...
Claudio G Brunstein, Paul V O'Donnell, Brent Logan, Peter Dawson, Luciano Costa
Transplantation and Cellular Therapy. 2022-07-01

Journal Articles

Impact of "real-world" interpretation of pre-transplant FDG-PET status on outcomes after allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma
Bachnova V, Burns LJ, Ahn KW, Laport GG, Akpek G, Kharfan-Dabaja MA, Nishihori T, Agura E, Armand P, Jaglowski SM, Cairo MS, Cashen AF, Cohen JB, D'Souza A, Freytes CO..., Biol Blood Marrow Transplant, 1/14/2015
Secondary Solid Cancer Screening Following Hematopoietic Cell Transplantation
Inamoto Y, Shah N, Savani B, Shaw B, Abraham A, Ahmed I, Akpek G, Atsuta Y, Baker K, Basak G, Bitan M, DeFilipp Z, Gregory T, Greinix H, Hamadani M, Hamilton B, Hayash..., Bone Marrow Transplantation, 1/1/2015
MALT lymphoma of the bladder: a case report and review of the literature
Vempati P, Knoll M, Alqatari M, Strauchen J, Malone AK and Bakst R, Case Reports in Hematology, 1/1/2015
Primary hepatic aspergillosis following induction chemotherapy for acute leukemia
Chasan R, Patel G, Malone A, Finn S, Huprikar S, Transplant Infectious Disease, 1/1/2013
Combined Bone Marrow and PBPC Autografts for Patients with Poor Mobilization
Sinitsyn Y, Malone A, Mandeli J, Grosskreutz C, Osman K, Scigliano E, Shi P, Isola L, Cytotherapy, 1/1/2009
Partial HLA Matching and Rh Incompatibility Resulting in Graft Versus Host Reaction and Evans' Syndrome after Liver Transplantation
Grosskreutz C , Gudzowaty O , Shi P, Rodriguez-Laiz G, Malone A, Isola L, Am J Hematol, 1/1/2008
Sacral chordoma: 40-year experience at a major cancer center
York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL, Neurosurgery, 1/1/1999
Join now to see all

Books/Book Chapters

HIV and Comorbidities: A Case Based Approach to Diagnosis and Management
Chapter: Oncology/Hematology
Malone A, Kim SA and Steinhagen RMEditors: Mullen MP, Caplivski D.Oxford University Press2008

Abstracts/Posters

Bendamustine-Brentuximab: Bridging to Transplant.
Steinberg A, Renteria A, Scigliano E, Hayes C, Kane M, Osman K, Malone A, Keyzner A and Isola L, ASBMT, 1/1/2015
Secondary Graft Failure in Allogeneic Stem Cell Transplantation for Myelofibrosis-A Single Institution Experience.
Keyzner A, Zhao Y, Renteria A, Malone A, Osman K, Scigliano E, Steinberg A and Isola L, ASBMT, 1/1/2015
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation.
Hayes CA, Isola L, Scigliano E, Osman K, Steinberg A, Keyzner A, Renteria A, Petersen B and Malone A, ASBMT, 1/1/2015
Palifermin Use in Lymphoma Patients Undergoing Autologous BEAM Transplants.
Steinberg A, Hayek C, Toal M, Ursol E, Galitzeck Z, Malone AK, Osman K, Scigliano E and Isola L, ASBMT, 1/1/2014
Oral Glutamine and Probiotics on Enteral Morbidity Following Autologous Stem Cell Transplantation for Plasma Cell Dyscrasias.
Renteria AS, Godbold J, Jakubowski RM, Rothwell A, Hayek C, Osman K, Malone AK, Jagannath S, Isola L and Chari A, ASBMT, 1/1/2013
Intensive July Onboarding in the Hematology/Oncology Fellowship: An Innovative Approach to Transition from Internal Medicine Residency to Subspecialty Training.
Malone A and Gabrilove J, Mount Sinai Institute for Medical Education 10th Annual Education Research Day, 1/1/2013
Outcome of Allogeneic Stem Cell Transplantation for Patients with Chronic Myelofibrosis and Blastic Transformation of Myelofibrosis.
Nieto MJ, Scigliano E, Grosskreutz C, Fruchtman S, Mascarenhas J, Osman K, Malone A, Cytryn S, Najfeld V, Hoffman R and Isola L, Blood (ASH Annual Meeting Abstracts), 1/1/2011
Novel Initiatives in Outpatient Training and Education for Hematology/Oncology Fellows.
Malone A and Gabrilove J, Mount Sinai Institute for Medical Education 8th Annual Education Research Day, 1/1/2011
GVHD Followed by Full Myeloid and Lymphoid Donor Chimerism After Cadaveric Liver Transplantation.
Malone AK, Gudzowaty O, Grosskreutz C, Scigliano E, Osman K, Choo Y and Isola L, ASBMT, 1/1/2010
Nonmyeloablative and Reduced Intensity Conditioning in Allogeneic Stem Cell Transplantation for Myelofibrosis.
Malone AK, Scigliano E, Grosskreutz C, Osman K and Isola L, ASBMT, 1/1/2010
Intra-Arterial Steroids for Systemic Steroid Resistant Graft-vs-Host Disease.
Stevens AM, Hu C, Isola L, Scigliano E, Grosskreutz C, Osman K, Malone A, Del Toro G, Weintraub J, ASBMT, 1/1/2009
Join now to see all